Royal Lifecure Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 09-01-2025
- Paid Up Capital ₹ 1.00 M
as on 09-01-2025
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -5.43%
(FY 2021)
- Profit 31.23%
(FY 2021)
- Ebitda 59.15%
(FY 2021)
- Net Worth 72.62%
(FY 2021)
- Total Assets 5.89%
(FY 2021)
About Royal Lifecure
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Amar Jaiswal, Ashish Jaiswal, Manish Jaiswal, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24299GJ2019PTC106202
- Company No.
106202
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jan 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Royal Lifecure Private Limited offer?
Royal Lifecure Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Nutraceuticals & Dietary Supplements, Fitness Supplements, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Pain Relief Drugs & Pharmaceuticals, Anti Inflammatory Drugs.
Who are the key members and board of directors at Royal Lifecure?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amar Jaiswal  | Director | 21-Jan-2019 | Current |
| Ashish Jaiswal | Director | 04-Feb-2019 | Current |
| Manish Jaiswal | Director | 18-Apr-2019 | Current |
| Dixit Shah | Director | 14-Jul-2020 | Current |
| Hiren Shah | Director | 14-Jul-2020 | Current |
Financial Performance of Royal Lifecure.
Royal Lifecure Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 5.43% decrease. The company also saw a substantial improvement in profitability, with a 31.23% increase in profit. The company's net worth Soared by an impressive increase of 72.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Royal Lifecure?
In 2021, Royal Lifecure had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Royal Lifecure?
Unlock and access historical data on people associated with Royal Lifecure, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Royal Lifecure, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Royal Lifecure's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
